Resistance Patterns of Escherichia coli and Klebsiella pneumoniae Bacteria Against Amikacin, Ceftazidime, Meropenem, Nitrofurantoin Antibiotics in Elderly Patients with UTI in RSUD Dr. Soetomo

Herdiyanti Herdiyanti, Lindawati Alimsardjono, Danti Nur Indiastuti

= http://dx.doi.org/10.20473/juxta.V10I12019.20-24
Abstract views = 742 times | downloads = 1954 times

Abstract


Introduction: Urinary tract infection (UTI) is an infection that involves the urinary tract, including the urethra, bladder, ureter, and kidneys. UTI is caused by microorganisms that breed in the urinary tract which are supposed to be free of microorganisms. Two bacterias that cause UTI in general are Escherichia coli and Klebsiella pneumoniae. UTI can occur at any age but generally occurs in the elderly. UTI caused by gram-negative bacteria can be killed with several examples of antibiotics namely amikacin, ceftazidime, meropenem and nitrofurantoin. These antibiotics found resistance to the bacteria that cause the UTI. This research is to determine the resistance patterns of Escherichia coli and Klebsiella pneumoniae bacteria against amikacin, ceftazidime, meropenem, nitrofurantoin antibiotics in elderly patients with UTI in Dr. Soetomo Surabaya January-June 2017 period.

Methods: A descriptive retrospective study in accordance with the logbook data of Clinical Microbiology Installation at Dr. RSUD. Soetomo Surabaya. Data from this study were taken from all populations that met the inclusion criteria. The results are presented by tables.

 Results: There are 163 elderly patient data which diagnosed with urinary tract infection. Escherichia coli resistance pattern against ceftazidime (75.6%), nitrofurantoin (12.6%) and meropenem (2.4%). Meanwhile, Klebsiella pneumoniae against ceftazidime (72.2%), nitrofurantoin (55.6%), meropenem (11.1%) and amikacin (2.8%).

 Conclusion: There were resistance number of Escherichia coli and Klebsiella pneumoniae bacteria against antibiotics amikacin, ceftazidime, meropenem, nitrofurantoin in elderly patients with UTI.


Full Text:

PDF

References


Urinary tract infection (UTI) [Internet]. Healthdirect.gov.au. 2018 [cited 14 October 2018]. Available from: https://www.healthdirect.gov.au/urinary-tract-infection-uti

Flores-Mireles A, Walker J, Caparon M, Hultgren S. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature Reviews Microbiology. 2015;13(5):269-284.

Beyene G, Tsegaye W. Bacterial Uropathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern in Jimma University Specialized Hospital, Southwest Ethiopia. Ethiopian Journal of Health Sciences. 2011;21(2).

Malmartel A, Ghasarossian C. Epidemiology of urinary tract infections, bacterial species and resistances in primary care in France. European Journal of Clinical Microbiology & Infectious Diseases. 2016;35(3):447-451.

Rowe T, Juthani-Mehta M. Urinary tract infection in older adults. Aging Health. 2013;9(5):519-528.

National Association For Continence [Internet]. Urinary Tract Infection | NAFC. 2017 [cited 14 October 2018]. Available from: https://www.nafc.org/urinary-tract-infection/

Hisano M, Bruschini H, Nicodemo A, Srougi M. Uncomplicated Urinary Tract Infections in Women in a Sao Paulo Quaternary Care Hospital: Bacterial Spectrum and Susceptibility Patterns. Antibiotics. 2014;3(1):98-108.

Ramirez M, Tolmasky M. Amikacin: Uses, Resistance, and Prospects for Inhibition. Molecules. 2017;22(12):2267.

Katzung B, Trevor A. Basic and clinical pharmacology. 2015.

Brunton L, Hilal-Dandan R, Knollmann B, Goodman L, Gilman A. The pharmacologial basis of theraputics. New York, etc.: McGraw-Hill; 2018.

WHO [Internet]. Mental health and older adults. 2016 [cited 15 October 2018]. Available from: http://www.who.int/mediacentre/factsheets/fs381/en/

Minardi D, d'Anzeo, Cantoro, Conti, Muzzonigro. Urinary tract infections in women: etiology and treatment options. International Journal of General Medicine. 2011;:333.

Gavazzi G, Delerce E, Cambau E, François P, Corroyer B, de Wazières B et al. Diagnostic criteria for urinary tract infection in hospitalized elderly patients over 75 years of age: A multicenter cross-sectional study. Médecine et Maladies Infectieuses. 2013;43(5):189-194.

Malmartel A, Ghasarossian C. Epidemiology of urinary tract infections, bacterial species and resistances in primary care in France. European Journal of Clinical Microbiology & Infectious Diseases. 2016;35(3):447-451.

BEHZADI P, BEHZADI E. A survey on urinary tract infections associated with the three most common uropathogenic bacteria [Internet]. PubMed Central (PMC). 2010 [cited 16 October 2018]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150015/

Jawetz E, Brooks G, Melnick J, Adelberg E, Carroll K, Hobden J et al. Jawetz, Melnick, & Adelberg's medical microbiology. 26th ed. New York: McGraw-Hill Medical; 2013.

Baroud M, Dandache I, Araj G, Wakim R, Kanj S, Kanafani Z et al. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases. International Journal of Antimicrobial Agents. 2013;41(1):75-79.

Ho P, Ng K, Lo W, Law P, Lai E, Wang Y et al. Plasmid-Mediated OqxAB Is an Important Mechanism for Nitrofurantoin Resistance in Escherichia coli. Antimicrobial Agents and Chemotherapy. 2015;60(1):537-543.

Ye Y, Xu L, Han Y, Chen Z, Liu C, Ming L. Mechanism for carbapenem resistance of clinical Enterobacteriaceae isolates. Experimental and Therapeutic Medicine. 2017;.

Fidecka-Skwarzynska M, Juda M, Maziarczyk L, Malm A. A preliminary report on the susceptibility to aminoglycosides of Escherichia coli isolated from the community-acquired urinary tract infections in adults in south-east Poland. Current Issues in Pharmacy and Medical Sciences. 2015;28(1):27-29.

Osei Sekyere J. Genomic insights into nitrofurantoin resistance mechanisms and epidemiology in clinical Enterobacteriaceae. Future Science OA. 2018;4(5):FSO293.

Yan J, Pu S, Jia X, Xu X, Yang S, Shi J et al. Multidrug Resistance Mechanisms of Carbapenem Resistant Klebsiella pneumoniae Strains Isolated in Chongqing, China. Annals of Laboratory Medicine. 2017;37(5):398.

Sharma A, Bakthavatchalam Y. Mechanisms of Carbapenem Resistance in K.pneumoniae and E. coli from Bloodstream Infections in India. Journal of Infectious Diseases & Therapy. 2016;4(4).

Liang C, Xing B. Molecular epidemiology of aminoglycosides resistance on Klebsiella pneumonia in a hospital in China [Internet]. PubMed Central (PMC). 2015 [cited 16 October 2018]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358596/


Refbacks

  • There are currently no refbacks.




Copyright (c) 2019 Herdiyanti Herdiyanti, Lindawati Alimsardjono, Danti Nur Indiastuti

INDEXED BY:

   

             

Creative Commons License

JUXTA (p-ISSN: 1907-3623, e-ISSN: 2684-9453) is licensed under Creative Commons Attribution-ShareAlike 4.0 International License.

 View JUXTA Stats